University of Alberta scientists find a new application for an existing drug, with potential to slow progression of the devastating degenerative disease.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig’s disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
The drug, called telbivudine, targets a protein that misfolds and does not function correctly in patients with ALS. “SOD1 is a protein that is known to misfold and misbehave in most cases of patients with ALS,” explained Ted Allison, associate professor in the Department of Biological Sciences and co-author on the study. “We showed that telbivudine can greatly reduce the toxic properties of SOD1, including improving the health of the subject’s motor neurons and improving movement.”
The research team used computer simulations to identify drugs with the potential for targeting the SOD1 protein. From this shortlist, the scientists identified and tested the most likely candidates—including telbivudine—using animal models.
“ALS is not well-understood,” said lead author Michele DuVal, who recently completed the PhD portion of the Faculty of Medicine & Dentistry’sMD/PhD program under the supervision of Allison. “We don’t yet know exactly what goes wrong first in the motor neurons or how the misbehaving SOD1 causes toxicity. Because there is still much to learn about the disease, the ALS research community focuses on both understanding ALS and on developing promising therapies.”
The discovery of telbivudine as a potential treatment is particularly exciting because the drug is already in use for treating patients with hepatitis. “It is already proven safe to use in patients, and it has very good potential for repurposing to use in a new clinical setting against ALS,” said Allison.
The Latest on: Lou Gehrig’s disease
via Google News
The Latest on: Lou Gehrig’s disease
- Services Set For Pat Quinn, Co-Founder Of Ice Bucket Challengeon November 27, 2020 at 11:23 am
Funeral arrangements have been announced for the co-founder of the popular Ice Bucket Challenge. Pat Quinn, a Yonkers resident, died Sunday at the age of 37. Visiting hours will be from 1 p.m. to 8 p.
- Will Congress Help This 36-Year-Old ALS Patient Waiting for Access to Experimental Drugs?on November 27, 2020 at 6:11 am
Mayuri Saxena’s only chance to live is through access to experimental drugs. Now Congress holds her fate in its hands.
- The untold truth of Lou Gehrigon November 25, 2020 at 12:43 pm
Gehrig was one of the first prominent people to be diagnosed with amyotrophic lateral sclerosis (ALS). Gehrig's battle with the disease was so public that his name was given to it; it was referred to ...
- Co-founder of ‘ice-bucket challenge’ dies at 37 of Lou Gehrig’s diseaseon November 24, 2020 at 11:17 pm
Pat Quinn was diagnosed with Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis, in 2013, a month after his 30th birthday, the ...
- Ice Bucket Challenge activist dies aged 37on November 23, 2020 at 2:00 pm
Patrick Quinn, the American man who helped drive the global phenomenon known as the Ice Bucket Challenge to tackle a deadly neuro-degenerative disease, has died aged 37.
- ALS disease: the causes and symptoms – as ice bucket challenge co-founder Patrick Quinn dies seven years after diagnosison November 23, 2020 at 8:28 am
Patrick Quinn, the co-creator of the ice-bucket challenge, has died seven years after he was diagnosed with ALS (amyotrophic lateral sclerosis) ...
- Co-founder of ‘bucket challenge’ dies at 37 from Lou Gehrig’s diseaseon November 23, 2020 at 3:48 am
Pat Quinn was diagnosed with Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis, in 2013, a month after his 30th birthday, the organization said in a statement announcing his death.
- Co-Founder of Viral ALS Ice Bucket Challenge Dies at 37on November 22, 2020 at 4:09 pm
A co-founder of the social media ALS ice bucket challenge, which has raised more than $200 million worldwide for Lou Gehrig’s disease research, died Sunday at the age of 37, according to the ALS ...
- Pat Quinn, co-founder of viral ALS Ice Bucket Challenge, dies at 37on November 22, 2020 at 3:53 pm
Quinn helped inspire participation in the social media challenge, which has raised more than $200 million worldwide for Lou Gehrig’s disease research.
- ALS ice bucket challenge co-founder dies at 37on November 22, 2020 at 3:33 pm
YONKERS, N.Y. — A co-founder of the social media ALS ice bucket challenge, which has raised more than $200 million worldwide for Lou Gehrig ‘s disease research, died Sunday at the age of 37, according ...
via Bing News